Item 2.02 Results of Operations and Financial Condition.
On
In addition, beginning on
The Press Release and Corporate Presentation contain information regarding certain of the Company's results of operations for 2022. Copies of the Press Release and Corporate Presentation are furnished as Exhibit 99.1 and Exhibit 99.2, respectively, and are incorporated herein by reference.
The Press Release and Corporate Presentation are being furnished pursuant to Item 2.02 of this Current Report on Form 8-K and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that Section, nor shall such document be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act except as shall be expressly set forth by specific reference in such filing.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits. Exhibit No. Description 99.1Ironwood Pharmaceuticals, Inc. Press Release datedJanuary 9, 2023 99.2 Corporate Presentation 104 The cover page from this Current Report on Form 8-K, formatted in Inline XBRL
© Edgar Online, source